Literature DB >> 12925060

An unusual cause of hyperinsulinaemic hypoglycaemia syndrome.

P J Manning1, E A Espiner, K Yoon, P L Drury, I M Holdaway, A Bowers.   

Abstract

Endogenous hyperinsulinism as a cause for hypoglycaemia can be attributed to a number of different causes including insulinoma, sulphonylurea drugs and the newly described disorder non-insulinoma pancreatogenous hypoglycaemia (NIPH). The calcium stimulation test is increasingly used as a method for not only localizing insulinoma but also for distinguishing the above entities. We describe a case in which felonious sulphonylurea administration was used to mimic either an insulinoma or NIPH. Importantly, this case demonstrates that, contrary to previous reports, the insulin response to calcium stimulation in such cases may be uniformly positive and should alert the physician to possible surreptitious sulphonylurea ingestion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925060     DOI: 10.1046/j.1464-5491.2003.01033.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  4 in total

1.  Colin Bouwer: professor of psychiatry and murderer.

Authors:  Vincent Marks; Caroline Richmond
Journal:  J R Soc Med       Date:  2008-08       Impact factor: 5.344

Review 2.  Insulin & C-peptide levels in sulfonylurea-induced hypoglycemia: a systematic review.

Authors:  Christopher R DeWitt; Kennon Heard; Javier C Waksman
Journal:  J Med Toxicol       Date:  2007-09

3.  Islet hyperplasia in adults: challenge to preoperatively diagnose non-insulinoma pancreatogenic hypoglycemia syndrome.

Authors:  Achim Starke; Christiane Saddig; Barbara Kirch; Cyrus Tschahargane; Peter Goretzki
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

4.  Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience.

Authors:  Jean-Marc Guettier; Anthony Kam; Richard Chang; Monica C Skarulis; Craig Cochran; H Richard Alexander; Steven K Libutti; James F Pingpank; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2009-02-03       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.